ID4 and glioblastoma: Because ID4 alone, as well as the SOX4 and OCT-4 complex, activates SOX2, and because chemoresistance is associated with both SOX2 and ID4 augmented expression, it is possible to speculate that multiple SOX2 activation events in GBM may impair patient prognosis.